Spineway SA (EPA:ALSPW)
France
· Delayed Price · Currency is EUR 0.1307
+0.0141 (12.09%)
Apr 1, 2025, 1:45 PM CET
Spineway Revenue
In the year 2024, Spineway had annual revenue of 11.95M EUR with 5.21% growth. Spineway had revenue of 5.29M in the half year ending December 31, 2024, with 4.82% growth.
Revenue
11.95M
Revenue Growth
+5.21%
P/S Ratio
n/a
Revenue / Employee
248.96K
Employees
54
Market Cap
32.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.95M | 592.00K | 5.21% |
| Dec 31, 2023 | 11.36M | 2.71M | 31.34% |
| Dec 31, 2022 | 8.65M | 3.61M | 71.76% |
| Dec 31, 2021 | 5.04M | 523.00K | 11.59% |
| Dec 31, 2020 | 4.51M | -1.07M | -19.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 44.29B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.78B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.43B |